Q3 2020 Sales Performance

Results reconciliation Q3 2020 gsk Total Intangible Intangible Major results amortisation impairment restructuring related Disposals, significant Transaction legal and other costs Separation Adjusted Turnover 8.6 results 8.6 (£bn) Operating 1.9 0.2 0.1 0.3 0.4 (0.2) <0.1 2.7 profit (£bn) EPS 25.0 3.1 1.0 5.0 4.3 (3.2) 0.4 35.6 (pence) Q3 19 EPS 31.4 3.4 0.4 3.4 5.7 (5.7) n/a 38.6 (pence) 88

View entire presentation